Glass Mitchell reported QCLS

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001493152-26-016911

Machine-readable

Structured copy

Timestamps

Event (reported)

Apr 13, 2026

Published

Apr 15, 2026

Ingested by INSIDER

Nov 5, 04:04 UTC

Last re-read

Nov 5, 04:04 UTC

Extracted facts

Filer

Glass Mitchell

Role

Director, Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

Q/C TECHNOLOGIES, INC. — Employee Stock Option (Right to Buy)

Ticker

QCLS

Shares

50.0K

Price per share

$0

Execution date (reported)

Apr 13, 2026

Owned after transaction

50.0K shares

Days from execution to publication

2

What this establishes

Glass Mitchell filed this Form 4 reporting a grant or award of QCLS on Apr 13, 2026. It became public on Apr 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, Chief Medical Officer

Glass Mitchellcik:0002023649

Issuer

Q/C TECHNOLOGIES, INC.cik:0001321834

Revision history · 0

No field has changed since this record was first ingested.